A system for the detection and early prediction of the approaching of exacerbations in patients suffering from chronic obstructive pulmonary disease (COPD)
COPD is the fourth leading cause of death in the world with a prevalence estimated at 4.5% (300 millions people in worldwide). COPD is often aggravated by acute episodes called exacerbations, from 2 to 4 flare-ups per year, and this represents the first leading cause of hospitalization and death. COPDmedia is an innovative medical device CE certified. It consists of a Bluetooth oximeter an APP for Smartphone that allows patients to monitor every day their health state and detect the onset of flare-ups and critical clinical situations, avoiding potential dangerous situations before symptoms appear. The device is able to detect potentially critical situations with a 98.4% accuracy index.
State of development
- "Health sector with application to COPD patients. It can be used in other pulmonary or non-pulmonary pathologies that may involve the respiratory system, including heart failure, severe obesity, neuromuscular diseases with respiratory muscle involvement. The device paves the way for a concrete path of ""Proactive Medicine"" offering answers to the health needs of citizens in their living environments. Patient acquires autonomy in the self-control of his pathology wherever she/he is."
- "The early diagnosis of COPD exacerbations is problematic because the patient tends to underestimate the symptoms and then comes to the doctor's attention late. Currently there is no methodology outlined but it has emerged the scientific need to identify parameters able to tell the doctor the best time to intervene. COPDmedia detect the onset of exacerbations or clinically critical situations before the symptoms arise for an early intervention."
- Venture capital financing - Licensing - Distribution Agreement - Industrial partnership